WorleyParsons year profit up 53%
August 12, 2008
Engineering services company WorleyParsons reports a 53% jump in full-year profit, riding a boom in mining and energy projects.
WorleyParsons' billion-dollar solar plan
WorleyParsons is studying the construction of the world's biggest project producing power from the sun's heat, tapping incentives for renewable energy generation.
WorleyParsons wins $5.3b coal project
Waratah Coal has appointed WorleyParsons as lead consultant and project manager for its $5.3 billion mine, rail and port development in central Queensland.
WorleyParsons awarded Fortescue contract
WorleyParsons Ltd has been awarded a lucrative contract for the second phase expansion of Fortescue Metals Group Ltd's iron ore development project.
WorleyParsons makes Canadian acquisition
Engineering and mining services company WorleyParsons has made an acquisition in Canada, purchasing Westmar Consultants for $A48.68 million.
Fortescue to double iron ore production
FORTESCUE METALS is forging ahead with plans to more than double its annual production capacity to 120 million tonnes of iron ore a year.
WorleyParsons profit up 61 per cent
Engineering company WorleyParsons has forecast higher earnings in the second half after posting a 61.6 per cent increase in half year profit.
WorleyParsons first half profit up 62%
WorleyParsons, Australia's biggest engineering company, has posted a 61.6 per cent increase in half year profit.
Orica to demerge consumer products
Orica Ltd plans to demerge its consumer products business into a separate company and raise up to $900 million through an entitlement offer.
Worley profit up 53%, mulls solar plant
WorleyParsons, Australia's largest engineering company, says the Pilbara region of WA could be a location for a $1 billion thermal solar power station.
Big jump for WorleyParsons as growth shot hits bullseye
AUSTRALIA'S largest engineering company, WorleyParsons, has met its ambitious growth targets with a 62 per cent jump in interim profit and forecast higher earnings in the second half.
Babcock plunges further
Babcock & Brown, Australia's second-largest investment bank, plunged further, falling almost a third in early trading.
ASX marginally in the red
The ASX was marginally in the red at noon, with gold stocks heavily sold off for the second consecutive day on the back of a falling gold price.
ASX high at noon as Wall St soars
The Australian stock market was up at noon as News Corporation Ltd reported robust fourth-quarter and full-year results.
08/06/08
Similar news about ANZ Bank
ASX lower led by financials, resources
The Australian share market closed more than two per cent lower, dragged down by the resource and financial sectors and a weak lead from Wall Street overnight.
No gas for Pluto 2 project as...
WOODSIDE Petroleum will have to continue its search for gas to feed a proposed second production train at its $12 billion Pluto liquefied natural gas project after a potential...
Turmoil for Qantas as craft grounded
QANTAS yesterday grounded a 747 aircraft because a crucial piece of equipment needed urgent maintenance, leaving the plane's tail at risk of breaking away.
Babcock & Brown shares dive on fee flow fears
Babcock & Brown, the worst- performing stock on the MSCI Asia-Pacific Index, fell on concerns that credit market turmoil may cut proceeds from asset sales to reduce debt.
Fairfax moves to unwind margin loan
THE Fairfax Media director John B. Fairfax has unwound a margin loan over 159 million of the publisher's shares, which was believed to have prompted short-sellers to target the stock over recent weeks.
Telstra delays dividend plan but...
TELSTRA has fallen short of bullish market expectations for profit growth this year, disappointing investors who had wanted to begin reaping more benefits from its lauded...
CSL to acquire Talecris for $3.4b
Blood products and vaccine firm CSL will acquire Talecris Biotherapeutics Holdings for $3.48 billion to boost its presence in the plasma therapeutics market.
08/13/08
Similar news about Acquisition
CSL to buy Talecris for $3.48b
CSL will buy Talecris Biotherapeutics Holdings, a plasma therapeutics business, for $3.48 billion.
08/13/08
Similar news about Acquisition
Stocks to watch
Stocks of interest on the Australian Stock Exchange today.
Telstra to outdo profit guidance
Telstra is expected to do better than its guidance when it reveals its annual profit results this week, as it increases revenue from its Next G mobile services.
Westpac's ray of light
Westpac has so far managed to avoid big problem credit exposures, and should it successfully swallow St George, will become Australia's biggest bank.